Is supper necessary to prevent overnight hypoglycaemia when using Lantus insulin?

• Conditions: Type 1 Diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12607000408482
• Lead Sponsor: Fergus Cameron

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-08-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Diagnosed with Type 1 Diabetes for greater than 1 year. Insulin regimen: established on a basal-bolus insulin regimen using glargine once daily and lispro/aspart (rapid-acting insulin) as evening bolus.HbA1c <8%Not currently on any other dietary restrictions.

Exclusion Criteria

HbA1c > 8%Currently on other dietary restrictionsInsulin regimen: using isophane or other intermediate insulinsNon-English speaking.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome measure will be the percentage of time hypoglycaemic (blood glucose level <4mmol/L).[Between 9pm and 7am during the 3-day treatment and control periods.]

Secondary Outcome Measures

Name	Time	Method
A secondary outcome from this study will be the percentage of time hyperglycaemic (blood glucose level >10mmol/L).[Between 9pm and 7am during the 3-day treatment and control periods.]